Absci ABSI
NASDAQ ABSI
$8.84 +0.03 (+0.40%)
As of: Sep 4, 2026 · 2:21 PM EDT

Absci (ABSI) Common Equity (2020 - 2026)

Absci (ABSI) posted Common Equity of $172.0 million for Q1 2026, down 9.23% sequentially from $189.4 million in Q4 2025, and down 13.49% YoY from $198.8 million in Q1 2025.

Analysis

Absci (ABSI) Common Equity (2020 - 2026) Analysis & Trends

Absci has reported Common Equity for 7 years, with the latest figure at $172.0 million in Q1 2026.

  • Quarterly Common Equity fell 13.49% year-over-year to $172.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $172.0 million (down 13.49% YoY) and the FY2025 annual result came in at $189.4 million, up 5.76% from the prior year.
  • Common Equity slipped to $172.0 million in Q1 2026 per ABSI's latest filing, from $189.4 million in the prior quarter.
  • Over five years, Common Equity peaked at $340.5 million in Q1 2022 and troughed at $172.0 million in Q1 2026.
  • A 5-year average of $226.6 million and a median of $210.3 million in 2025 frame the typical range for Common Equity.
  • The sharpest annual moves came in 2022 and 2023: Common Equity jumped 445.67% in 2022, then sank 35.8% in 2023.
  • Over 5 years, Common Equity stood at $274.4 million in 2022, then tumbled by 35.8% to $176.2 million in 2023, then grew by 1.68% to $179.1 million in 2024, then increased by 5.76% to $189.4 million in 2025, then declined by 9.23% to $172.0 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods registered $172.0 million, $189.4 million, and $210.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 20.25 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 31.71 Bn
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn 8.42 Bn
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn 6.76 Bn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 2.61 Bn
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 5.17 Bn
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn 1.35 Bn
8 Royalty Pharma 28.42 Bn 27.59 Bn - 9.79 Bn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 757.49 Mn
10 Absci 1.40 Bn 1.19 Bn - 246.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 246.13 Mn
Mar 31, 2026 171.97 Mn
Dec 31, 2025 189.45 Mn
Sep 30, 2025 210.34 Mn
Jun 30, 2025 173.37 Mn
Mar 31, 2025 198.80 Mn
Dec 31, 2024 179.13 Mn
Sep 30, 2024 201.34 Mn
Jun 30, 2024 221.49 Mn
Mar 31, 2024 240.11 Mn
Dec 31, 2023 176.18 Mn
Sep 30, 2023 196.42 Mn
Jun 30, 2023 215.40 Mn
Mar 31, 2023 253.97 Mn
Dec 31, 2022 274.41 Mn
Sep 30, 2022 292.94 Mn
Jun 30, 2022 316.19 Mn
Mar 31, 2022 340.50 Mn
Dec 31, 2021 366.11 Mn
Sep 30, 2021 388.01 Mn